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G lobally, an increasingnumber of patients are
suffering from end-stage renal
disease (ESRD) treated by re-
nal replacement therapy. It is
estimated that by 2010, there
may be an excess of 2 million
patients with ESRD worldwide,
mostly living in the West, where
access to care is available and
affordable.1 In developed coun-
tries approximately 0.1% of the
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A166population have ESRD,
whereas the health care cost of
treatment often exceeds 1% of
health care budgets. Those liv-
ing in low and middle econo-
mies can seldom access or af-
ford renal replacement therapy
and consequently often die of
ESRD.
Estimates from the United
States imply that up to 11% of
the general population may be
affected by some degree of
chronic kidney damage/disease.2
Although such estimates may be
inflated, they have drawn global
attention to the growing prob-
lem of chronic kidney disease
(CKD) and its likely impact on
morbidity and mortality from
other chronic noncommunicable
diseases. In a country such as
China, it has been estimated that
the CKD prevalence may be ap-
proximately 2% to 3%, raising
the spectrum of more than 10 to
Approximately 1.2 billion individual
d), and 2.7 billion live in moderate pov
developing countries, but does not sp
discrepancies have been reported.
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and management of chronic diseases
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impact of poverty on CKD or indirectly
linked to poverty-associated diabete
have shown that the poor and socia
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tion are emerging as major risk m
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review therefore aims to look at the
major risk factors, namely, diabetes a
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merican Journal of Kidney Diseases, Vol 5in this country alone.3 However,
the majority of patients with
CKD are unlikely to reach
ESRD because they often die of
cardiovascular disease (CVD)
during the earlier stages of the
disease.4 This could consider-
ably add to the global burden of
CVD, the major cause of global
chronic noncommunicable dis-
ease mortality, accounting for
30% of chronic disease deaths
and exceeding 18 million
deaths annually.5
With this in mind, it is im-
perative to focus attention on
the risk markers and factors
that predispose to CKD within
communities. These are simi-
lar to those causing CVD and
include hypertension, diabetes,
obesity, and possibly other fac-
tors, such as dyslipidemia and
smoking. The links between
CKD and CVD are so inter-
twined that CKD could easily
ldwide live in extreme poverty ($1/
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World Kidney Forum 167age.” Socioeconomic status
(SES) impacts on cardio-kidney
damage risk factors. It therefore
is the objective of this review to
describe the impact of SES on
CKD and its major risk fac-
tors, diabetes and hyperten-
sion, in developed and develop-
ing countries.
POVERTY AND ITS IMPACT
ON CKD/ESRD
Poverty can be defined in
numerous ways. Many coun-
tries have individual poverty
lines related to average income
and identify the numbers of
those living below these thresh-
olds. Absolute poverty is clas-
sified by the World Bank as
less than $1/d or $2/d.6 In de-
veloped countries, a measure
of relative poverty is more
usual, eg, the European Union
defines this as an income less
than 60% of the median in-
come of the society.6,7 Approxi-
mately 1.2 billion people in the
world live in extreme poverty
($1/d), and 2.7 billion live
in moderate poverty ($2/d;
Fig 1).6,8
Research supports the im-
portance of socioeconomic
characteristics for individual
and population health in 2
ways.9 First, an individual’s so-
cioeconomic stratification is a
major determinant of his or her
health. Second, the socioeco-
nomic profile of areas where in-
dividuals live may have effects
on their health regardless of their
own SES. Pathways for the ef-
fects of area socioeconomic and
racial/ethnic characteristics on
health are shown in Fig 2.9
In addition, poverty may im-
pact on access and adherence to
health care provision. Individu-als without a usual source of
health care may receive less
screening, follow-up care, and
timely treatment. For example,
fewer physicians per proportion
of population may predict a rela-
tive lack of access to preventive
care by delaying the detection
and treatment of hypertension
and diabetes and thus causing
delay in the detection and pre-
vention of CKD. Income-based
disparities in health care may be
caused by an inability of less
affluent patients to overcome
structural barriers to care, finan-
cial barriers faced by poorer pa-
tients that might be overcome
with health insurance, or per-
sonal and environmental factors
that differ by SES, eg, health-
related behaviors or occupa-
tional status.10
There is a growing body of
evidence suggesting that the
incidence of CKD may be in-
creased in those with low SES.
A case-control study in Sweden,
by using 2 of 3 SES variables
(educational, occupational, and
income and economic well-be-
ing), analyzed all adult native
residents from May 1996 to May
1998 and found that the risk of
CKD increased by 110% and
60% in unskilled female and
male workers relative to indi-
viduals living in a family in
which at least 1 member was a
professional, respectively.11 This
study also reported that those
with 9 years or less of schooling
had a 30% greater risk of CKD
compared with those with a uni-
versity education. A recent pro-
spectiveUScommunity-basedco-
hort study, the Third National
Health and Nutrition Examina-
tion Survey (NHANES III), sug-
gested that potentially modifiable
factors, such as lower SES, subop-timal health behaviors, and poor
glycemic and blood pressure con-
trol, account for more than 80%
of CKD prevalence disparities
within the community.12
CKD stages 1 and 2 are of-
ten defined by the presence of
microalbuminuria. This prob-
ably is misleading and contrib-
utes to inflating the prevalence
of CKD. Microalbuminuria
most likely is a marker of dif-
fuse vascular damage, including
cardio-kidney damage, and mi-
croinflammation, rather than
CKD per se. A number of sur-
veys in the United States, Euro-
pean Union, and Australia sug-
gest that approximately 6% to
10% of the general population
may have albuminuria and that
it predicts CVD death and all-
cause mortality.13 Socioeco-
nomic factors, such as lifestyle,
SES, and occupational expo-
sures, may impact on albumin-
uria, CKD, and CVD. An eco-
logical analysis using data from
NHANES III showed that pov-
erty (200% federal poverty
level) was associated with in-
creased risk of both microalbu-
minuria (odds ratio [OR], 1.35)
and macroalbuminuria (OR,
1.78).14 The association of less
than 200% federal poverty
level with microalbuminuria
persisted in a multivariate
model adjusting for age, sex,
race, education, obesity, hyper-
tension, diabetes, decreased
glomerular filtration rate, and
medication use (OR, 1.18). Al-
buminuria is a major risk fac-
tor for CVD and, to a lesser
extent, CKD, whereas mac-
roalbuminuria is a well-estab-
lished poor prognostic marker
for the progression of CKD.
The association of poverty with
albuminuria/proteinuria there-
y country, showing the percentage of population living in extreme poverty (income $1/d). Reprinted with permission from The World Bank.8Figure 1. Map of world poverty b
rmiss
World Kidney Forum 169fore may influence the inci-
dence and progression of CKD.
Also, limited data are avail-
able to suggest that the rate of
progression of CKD may be
affected by SES. A US cohort
study of 4,735 Cardiovascular
Health Study participants re-
ported that the incidence of
progressive CKD is inversely
related to area-level SES: 18
per 1,000 of the population for
the lowest area-level quartile
compared with 10 per 1,000 for
those living in more affluent
neighborhoods.15 After adjust-
ing for a number of covariates,
including age, sex, and baseline
creatinine level, this study also
showed that living in the lowest
SES quartile was associated with
a 60% greater risk of progres-
sive CKD compared with living
in the highest quartile.
There are considerable racial
and ethnic variations in the inci-
dence and prevalence of ESRD.
In the United States, Australia,
and the United Kingdom, the
incidence/prevalence of ESRD
is much greater in ethnic minori-
ties compared with whites.16-18
These variations have been at-
tributed to genetic, racial, and
socioeconomic influences, in-
Figure 2. Effects of area socioeco
health. Direct or intensifying effect (s
effect (dotted arrow). Adapted with pecluding the limited access tohealth care provision of disad-
vantaged ethnic minorities that
may predispose to CKD, as
well as to a faster rate of pro-
gression to ESRD. The inci-
dence of treated ESRD in the
United States was inversely re-
lated to poverty and household
income level for both white
and nonwhite populations. A
study based on the US Renal
Data System (USRDS) data-
base (1983 to 1988) showed
that for whites and African
Americans, the respective rela-
tive risks (RRs) of ESRD were
1.21 and 1.10 for those with an
annual income up to US
$10,000 in comparison to 0.77
(whites) and 0.69 (African
Americans) for those earning
in excess of $25,000 per an-
num.19 In this study, the 3 SES
variables of per-capita income,
percentage of college gradu-
ates, and percentage living in
poverty highly correlated. An-
other US study of 11,346 pa-
tients of all ages explored the
different geographical distribu-
tions of ESRD and showed that
incidence rates were consis-
tently greater in rural com-
pared with urban counties20;
population per physician den-
ic and racial/ethnic characteristics on
arrow) and moderating or reciprocal
ion from House and Williams.9sity (RR, 0.49) and rural resi-dence (adjusted RR, 1.66) af-
fected the incidence of ESRD.
In Texas, a retrospective analy-
sis calculated indirect ESRD
prevalence rates for each of the
80 counties (19,336 patients)
and reported that SES and eth-
nicity accounted for approxi-
mately 94% of intercounty
variation in ESRD, including
that secondary to diabetic ne-
phropathy.21 A study examin-
ing the association between
ESRD incidence rates caused
by hypertension and neighbor-
hood-level measures of SES
derived from a random house-
hold survey showed that com-
munities with lower educa-
tional and income levels tended
to have greater ESRD inci-
dence rates.22 In Australia, a
study reported that those living
in more disadvantaged areas
are at greater risk of ESRD.23
SES not only has been associ-
ated with the incidence/preva-
lence of ESRD, but it may also
impact on quality of life in pa-
tients with ESRD. A prospective
study evaluated the quality of
life of 180 patients with ESRD
by using mean scores for 36-
Item Short Form Health Survey
scales for low- and high-SES
groups and found that SES con-
tinued to significantly affect all
quality-of-life dimensions, in-
cluding functional capacity,
physical aspect, and general
health status, as well as social,
emotional, and mental aspects.24
In addition to the role of
SES on the incidence and
prevalence of ESRD, a cohort
study also suggested that socio-
demographic factors have
strong independent effects on
access to transplantation.25 A
prospective cohort study ofnom
olid3,165 patients with ESRD
diabe
et al.
Hossain et al170noted that neighborhood in-
comes were strongly associ-
ated with both mortality and
placement on the renal trans-
plant waiting list26; increas-
ing neighborhood income was
associated with decreased
mortality and an increased
likelihood of being listed for
transplantation.
POVERTY AND ITS IMPACT
ON CKD MODIFIABLE
RISK FACTORS
CKD is a complex and often
progressive condition that leads
to both CVD and ESRD. In ad-
dition to the underlying suscepti-
bility to CKD, some risk factors
have a role in the initiation of
kidney damage, whereas others
are implicated in the progres-
sion of established CKD to
ESRD.
A number of modifiable and
nonmodifiable risk factors have
been associated with the devel-
opment and progression of CKD.
Race, ethnicity, and genetics
have major impacts on suscepti-
Figure 3. Global prevalence of
printed with permission from Hossainbility to CKD. Of the modifiablefactors for the initiation of CKD
in the community, hypertension
and diabetes are the most com-
mon; however, obesity, dyslipi-
demia, and smoking have also
been implicated.
SES therefore may impact
directly or indirectly on the sus-
ceptibility to and progression
of CKD. It also may impact on
risk factors for CKD and car-
dio-kidney damage in the com-
munity, such as hypertension,
diabetes, and obesity. In the
following section, we review
some of the data linking pov-
erty and social deprivation to
the major cardio-kidney dam-
age risk factors, namely, diabe-
tes and hypertension.
Poverty, DiabetesMellitus,
andCKD
Globally, diabetes is rapidly
emerging as a pandemic health
care problem; the number of
people with diabetes worldwide
is projected to increase from 171
million in 2000 to 366 million
by 2030 (Fig 3).27,28 In develop-
tes mellitus (2000 and 2030). Re-
28ing countries, this increase willbe more noticeable because the
number of people with diabetes
is expected to increase from 84
million to 228 million. Accord-
ing to the World Health Organi-
zation (WHO), India and China
will be facing the greatest chal-
lenges. In these countries, the
prevalence of diabetes is much
greater in urban westernized ag-
glomerations compared with ru-
ral areas.
In the West and westernized
societies, poverty is being rec-
ognized as a contributor to the
prevalence of diabetes melli-
tus. Several studies reported
that the prevalence of diabetes
is greater in individuals ex-
posed to more deprivation at
both individual and residential-
area levels. In the United
States, NHANES III provided
evidence that SES is associ-
ated inversely with the preva-
lence of diabetes mellitus for
both African Americans and
whites.29 It was noted that the
prevalence of diabetes is more
strongly associated with pov-
erty income ratio than with
education or occupational sta-
tus. In the United Kingdom, a
population-based study in the
city of Manchester showed a
greater prevalence of type 2
diabetes in all ethnic groups,
including whites, with an an-
nual household income less
than £10,000 ($15,000).30 A
cross-sectional study of urban
indigenous Australian volun-
teers in the Darwin region re-
ported that the prevalence of
diabetes was inversely associ-
ated with lower SES; the rela-
tive odds of diabetes was 2.66
(95% confidence interval [CI],
1.71 to 4.51) for lower SES.31
Worldwide, diabetes is rap-
idly becoming the most com-
World Kidney Forum 171mon cause of ESRD. Diabetic
nephropathy develops in ap-
proximately one-third of pa-
tients with diabetes, and its in-
cidence is increasing rapidly in
developing countries, includ-
ing those in the Asia-Pacific
region that are the most se-
verely affected. A recent multi-
national survey in Europe, Can-
ada, and the Asia-Pacific region
reported that the incidence of
ESRD caused by type 2 diabe-
tes increased annually by 9.9%
from 1998 to 2002.32 Another
survey across 10 Asian coun-
tries reported that diabetic ne-
phropathy was the most com-
mon cause of ESRD in 9 of 10
Asian countries, and its preva-
lence increased from 1.2% of
the overall population with
ESRD in 1998 to 14.1% in
2000.33 At the same time, in
China, the number of diabetic
nephropathy–induced ESRD
cases increased from 17% in
the 1990s to 30% in 2000. In
India, diabetic nephropathy is
expected to develop in 6.6 mil-
lion of the 30 million patients
with diabetes. These statistics
show that diabetes and associ-
ated nephropathy are increas-
ing at an alarming rate in devel-
oping countries, where health
care resources may be unable
Figure 4. Global prevalence of h
with permission from Kearney et al.35to meet the challenge.Poverty, Hypertension,
andCKD
There is little doubt that hy-
pertension is, along with diabe-
tes, a major cause of CKD
worldwide. A large number of
studies, including the Multiple
Risk Factor Intervention Trial
(MRFIT) with more than
300,000 US men, linked sys-
tolic and diastolic hyperten-
sion to the development of
CKD.34
Worldwide, hypertension is
on the increase, with the num-
ber of those affected increas-
ing from the current level of
972 million to 1.56 billion by
2025, with developing coun-
tries most severely affected
(Fig 4).35 The global increase
in hypertension is affected by
strong socioeconomic influ-
ences. The increasing burden
of hypertension in develop-
ing countries has been attrib-
uted to several indicators: ur-
banization, sedentary lifestyle,
obesity, physical inactivity, smok-
ing, and increased alcohol con-
sumption. Recently, the Guide-
lines Sub-Committee of theWHO
International Society of Hyperten-
sion Mild Hypertension Liaison
Committee reported that in Asian
countries, the prevalence of hyper-
tension has considerably in-
creased, with prevalence in some
tension (2000 and 2025). Reprintedurban areas reaching 24%.36The WHO Stepwise Approach
to Surveillance survey showed
that the majority of those with
hypertension in Asia are un-
aware of the condition: 83% in
Vietnam, 49% in India, 55.3%
in China, and 75.7% in Ko-
rea.37 This survey also showed
that both men and women with
the lowest educational levels
were more likely to be hyper-
tensive (30.9% and 13.3% for
men and women, respectively)
compared with those better
educated (17.5% and 10.9%,
respectively).
In the West, a large body of
evidence also links social de-
privation and hypertension.
SES is associated inversely
with a greater prevalence of
hypertension and poor thera-
peutic control. In the United
States, the NHANES I Epide-
miological Follow-up Study
showed that the RR of hyper-
tension was greater in those
with less than 12 years of
education compared with
those with longer education
spans (RR in men, 2.14 [95%
CI, 0.63 to 2.14] and RR in
women, 2.06 [95% CI, 1.39
to 3.05]).38 Recently, the IH-
PAF Study (Incidence de
I’HTA dans la Population Ac-
tive Française, or socioeco-
nomic inequalities in hyper-
tension prevalence and care
in the working French popula-
tion), a cross-sectional analy-
sis of a cohort of 29,656 indi-
viduals, reported that the
prevalence of hypertension is
significantly greater in both
male and female unskilled
workers (13.9% and 7.1%)
compared with skilled execu-
tives (11.6% and 4.1%, re-
spectively).39 In Finland, ayper34-year follow-up study of
Hossain et al172school children showed that
occupational categories are
inversely associated with the
prevalence of hypertension:
40% in lower grade occupa-
tions compared with 26% in
higher grade occupations.40 In
terms of occupation and in-
come as indicators of social
class, a cross-sectional study
in Spain reported that indi-
viduals of low social class
had a greater prevalence of
hypertension than those in the
high social class.41
The incidence and progres-
sion of CKD are associated
strongly with control of sys-
temic hypertension. Both sys-
tolic and diastolic increased
blood pressures have been im-
plicated.42 Several studies
documented that tight control
of blood pressure varies
among individuals depending
on their area of residence and
occupation. The NHANES III
reported that uncontrolled
blood pressure is strongly as-
sociated with individuals with
poorer cognitive function.43 In
this survey, in individuals with
the lower quartile Mini-Mental
State Examination score, a
larger number of subjects were
less educated, with less than
12 years (66%), and had lower
income, at less than $20,000
(71.1%), compared with those
in the upper quartile (28.2%
and 37.8%, respectively).43 In
France, the IHPAF study re-
ported that after adjustment for
age and behavioral factors, be-
ing an unskilled worker is a sig-
nificant risk factor for poor blood
pressure control (OR, 1.78; 95%
CI, 1.23 to 2.58).39 In Poland, a
hospital-based survey of 222 pa-
tients showed that regular medi-
cine intake was more commonin urban dwellers (64.9%), indi-
viduals with higher education
(71.7%), and those who are em-
ployed (67.4%) compared with
those living in socially deprived
areas and unemployed.44 In
China, a community-based sur-
vey showed that poorly con-
trolled blood pressure was
found in individuals living in
rural areas (46.6%) compared
with those who lived in cities
(23.9%).45
CONCLUSIONS
The global increase in and
awareness of CKD has
prompted considerable inter-
est in its early detection, pre-
vention, and management. It
also has focused minds on risk
markers and factors involved
in the initiation and progres-
sion of CKD and its cardiovas-
cular complications. A number
of factors have been identified,
primarily hypertension and dia-
betes. However, little attention
has been given to date to the
fact that these 2 major predis-
posing factors may be linked
to social deprivation and pov-
erty. This review shows strong
links between social deprivation
and factors leading to CKD and
CVD, thus suggesting a radical
change in emphasis to the pre-
vention of CKD based on the
identification and correction
of issues related to poverty
and impacting on kidney
health care. Solutions that tar-
get social determinants of
health care may in the long
run impact positively on the
current health care disparities
affecting patients with diabe-
tes, hypertension, and cardio-
kidney disease.ACKNOWLEDGEMENTS
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1082-1085, 2003APPENDIX: SEARCH
STRATEGY
The authors searched PubMed/
MEDLINE to identify the articles
(1990 to 2008) related to poverty
and CKD. Key words used individu-
ally and in association: poverty, de-
privation, socioeconomic status,
CKD, ESRD, diabetes mellitus
(DM), and hypertension (HTN). We
also referred to data reported in large
national and international registries:
the USRDS, Australia and New Zea-
land Dialysis and Transplant Regis-
try (ANZDATA), UK Renal Regis-
try, WHO, and World Bank. In this
search only English publicationswere considered. For CKD studies,
we have commented on all those
relevant to the association of social
deprivation and incidence and preva-
lence of CKD. These studies are
mostly from the developed world.
We identified 251 publications con-
cerning associations between pov-
erty and hypertension and 552 ar-
ticles pertaining to the association
between poverty and diabetes. We
have mainly restricted ourselves to
large WHO and multinational stud-
ies and surveys from both the West
and developing countries. In gen-
eral, we have excluded small and
single-country studies unless they
highlighted a key point.
